Examining the frequency of stimulant misuse among patients with primary disorders of hypersomnolence

A retrospective cohort study

William G. Mantyh, Robert R Auger, Timothy Ian Morgenthaler, Michael H. Silber, Wendy R. Moore

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Study Objectives: Narcolepsy and idiopathic hypersomnia are commonly treated by sleep specialists and encountered by other medical providers. Although pharmacotherapy with modafinil and traditional stimulants is considered the mainstay of treatment, physicians are often uncomfortable with their prescription because of concerns regarding misuse. The goal of this study was to assess the frequency of stimulant misuse in this population. Methods: A retrospective cohort study was performed evaluating patients 18 years and older diagnosed with narcolepsy with and without cataplexy and idiopathic hypersomnia with and without long sleep between 2003-2008. Patients were included if they obtained stimulant prescriptions from and had at least one follow-up visit subsequent to initial diagnosis at our center. Stimulant misuse was defined by multiple prescription sources or early refill requests, which are systematically entered into the record by nursing staff. Results: A total of 105 patients met inclusion criteria for the study; 45 (42%) were male. Mean age at multiple sleep latency test was 42 (± 16). Twelve (11%) patients had a history of illicit substance misuse, and one (1%) patient demonstrated previous stimulant misuse. Fifty-seven (54%) patients carried psychiatric diagnoses, 88% of whom reported depression. Median duration of monitored stimulant therapy was 26 months (range 1-250). None of the 105 patients was found to have evidence of stimulant misuse. Conclusion: This study suggests that the frequency of stimulant misuse in patients with narcolepsy and idiopathic hypersomnia is extremely low. Concerns regarding drug misuse should not leverage decisions to provide long-term therapy.

Original languageEnglish (US)
Pages (from-to)659-662
Number of pages4
JournalJournal of Clinical Sleep Medicine
Volume12
Issue number5
DOIs
StatePublished - 2016

Fingerprint

Disorders of Excessive Somnolence
Cohort Studies
Retrospective Studies
Idiopathic Hypersomnolence
Narcolepsy
Prescriptions
Sleep
Cataplexy
Nursing Staff
Mental Disorders
Therapeutics
Depression
Physicians
Drug Therapy

Keywords

  • Narcolepsy
  • Primary hypersomnolence
  • Stimulant misuse

ASJC Scopus subject areas

  • Clinical Neurology
  • Pulmonary and Respiratory Medicine
  • Neurology

Cite this

Examining the frequency of stimulant misuse among patients with primary disorders of hypersomnolence : A retrospective cohort study. / Mantyh, William G.; Auger, Robert R; Morgenthaler, Timothy Ian; Silber, Michael H.; Moore, Wendy R.

In: Journal of Clinical Sleep Medicine, Vol. 12, No. 5, 2016, p. 659-662.

Research output: Contribution to journalArticle

@article{f5f0f2ffdaa948caaf09d5db21f4f8e8,
title = "Examining the frequency of stimulant misuse among patients with primary disorders of hypersomnolence: A retrospective cohort study",
abstract = "Study Objectives: Narcolepsy and idiopathic hypersomnia are commonly treated by sleep specialists and encountered by other medical providers. Although pharmacotherapy with modafinil and traditional stimulants is considered the mainstay of treatment, physicians are often uncomfortable with their prescription because of concerns regarding misuse. The goal of this study was to assess the frequency of stimulant misuse in this population. Methods: A retrospective cohort study was performed evaluating patients 18 years and older diagnosed with narcolepsy with and without cataplexy and idiopathic hypersomnia with and without long sleep between 2003-2008. Patients were included if they obtained stimulant prescriptions from and had at least one follow-up visit subsequent to initial diagnosis at our center. Stimulant misuse was defined by multiple prescription sources or early refill requests, which are systematically entered into the record by nursing staff. Results: A total of 105 patients met inclusion criteria for the study; 45 (42{\%}) were male. Mean age at multiple sleep latency test was 42 (± 16). Twelve (11{\%}) patients had a history of illicit substance misuse, and one (1{\%}) patient demonstrated previous stimulant misuse. Fifty-seven (54{\%}) patients carried psychiatric diagnoses, 88{\%} of whom reported depression. Median duration of monitored stimulant therapy was 26 months (range 1-250). None of the 105 patients was found to have evidence of stimulant misuse. Conclusion: This study suggests that the frequency of stimulant misuse in patients with narcolepsy and idiopathic hypersomnia is extremely low. Concerns regarding drug misuse should not leverage decisions to provide long-term therapy.",
keywords = "Narcolepsy, Primary hypersomnolence, Stimulant misuse",
author = "Mantyh, {William G.} and Auger, {Robert R} and Morgenthaler, {Timothy Ian} and Silber, {Michael H.} and Moore, {Wendy R.}",
year = "2016",
doi = "10.5664/jcsm.5788",
language = "English (US)",
volume = "12",
pages = "659--662",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "5",

}

TY - JOUR

T1 - Examining the frequency of stimulant misuse among patients with primary disorders of hypersomnolence

T2 - A retrospective cohort study

AU - Mantyh, William G.

AU - Auger, Robert R

AU - Morgenthaler, Timothy Ian

AU - Silber, Michael H.

AU - Moore, Wendy R.

PY - 2016

Y1 - 2016

N2 - Study Objectives: Narcolepsy and idiopathic hypersomnia are commonly treated by sleep specialists and encountered by other medical providers. Although pharmacotherapy with modafinil and traditional stimulants is considered the mainstay of treatment, physicians are often uncomfortable with their prescription because of concerns regarding misuse. The goal of this study was to assess the frequency of stimulant misuse in this population. Methods: A retrospective cohort study was performed evaluating patients 18 years and older diagnosed with narcolepsy with and without cataplexy and idiopathic hypersomnia with and without long sleep between 2003-2008. Patients were included if they obtained stimulant prescriptions from and had at least one follow-up visit subsequent to initial diagnosis at our center. Stimulant misuse was defined by multiple prescription sources or early refill requests, which are systematically entered into the record by nursing staff. Results: A total of 105 patients met inclusion criteria for the study; 45 (42%) were male. Mean age at multiple sleep latency test was 42 (± 16). Twelve (11%) patients had a history of illicit substance misuse, and one (1%) patient demonstrated previous stimulant misuse. Fifty-seven (54%) patients carried psychiatric diagnoses, 88% of whom reported depression. Median duration of monitored stimulant therapy was 26 months (range 1-250). None of the 105 patients was found to have evidence of stimulant misuse. Conclusion: This study suggests that the frequency of stimulant misuse in patients with narcolepsy and idiopathic hypersomnia is extremely low. Concerns regarding drug misuse should not leverage decisions to provide long-term therapy.

AB - Study Objectives: Narcolepsy and idiopathic hypersomnia are commonly treated by sleep specialists and encountered by other medical providers. Although pharmacotherapy with modafinil and traditional stimulants is considered the mainstay of treatment, physicians are often uncomfortable with their prescription because of concerns regarding misuse. The goal of this study was to assess the frequency of stimulant misuse in this population. Methods: A retrospective cohort study was performed evaluating patients 18 years and older diagnosed with narcolepsy with and without cataplexy and idiopathic hypersomnia with and without long sleep between 2003-2008. Patients were included if they obtained stimulant prescriptions from and had at least one follow-up visit subsequent to initial diagnosis at our center. Stimulant misuse was defined by multiple prescription sources or early refill requests, which are systematically entered into the record by nursing staff. Results: A total of 105 patients met inclusion criteria for the study; 45 (42%) were male. Mean age at multiple sleep latency test was 42 (± 16). Twelve (11%) patients had a history of illicit substance misuse, and one (1%) patient demonstrated previous stimulant misuse. Fifty-seven (54%) patients carried psychiatric diagnoses, 88% of whom reported depression. Median duration of monitored stimulant therapy was 26 months (range 1-250). None of the 105 patients was found to have evidence of stimulant misuse. Conclusion: This study suggests that the frequency of stimulant misuse in patients with narcolepsy and idiopathic hypersomnia is extremely low. Concerns regarding drug misuse should not leverage decisions to provide long-term therapy.

KW - Narcolepsy

KW - Primary hypersomnolence

KW - Stimulant misuse

UR - http://www.scopus.com/inward/record.url?scp=84969218894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969218894&partnerID=8YFLogxK

U2 - 10.5664/jcsm.5788

DO - 10.5664/jcsm.5788

M3 - Article

VL - 12

SP - 659

EP - 662

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 5

ER -